C
Krystal Biotech, Inc. KRYS
$183.92 $1.170.64%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 116.26% 879.91% -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue 116.26% 879.91% -- -- --
Cost of Revenue 72.38% 2,897.31% -- -- --
Gross Profit 119.47% 825.92% -- -- --
SG&A Expenses 26.34% 21.17% 6.65% 8.42% 1.65%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 27.57% 41.56% 29.36% 8.56% 11.12%
Operating Income 1,218.64% 234.39% 155.37% 116.01% 108.94%
Income Before Tax 356.13% -63.13% 148.31% 102.06% 133.25%
Income Tax Expenses 59.34% -- -- -- --
Earnings from Continuing Operations 423.23% -66.34% 146.88% 102.06% 127.12%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 423.23% -66.34% 146.88% 102.06% 127.12%
EBIT 1,218.64% 234.39% 155.37% 116.01% 108.94%
EBITDA 934.35% 239.70% 160.68% 118.10% 111.84%
EPS Basic 412.51% -67.13% 143.70% 101.87% 124.73%
Normalized Basic EPS 346.77% 314.40% 180.12% 137.22% 130.01%
EPS Diluted 409.41% -67.38% 142.40% 101.70% 123.94%
Normalized Diluted EPS 339.94% 312.12% 177.32% 135.95% 129.32%
Average Basic Shares Outstanding 2.08% 2.40% 7.28% 10.05% 9.69%
Average Diluted Shares Outstanding 3.70% 3.50% 11.18% 13.92% 12.22%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings